- For people with atopic dermatitis, a new drug targeting the condition has just been approved by the FDA.
- The drug, from Eli Lilly, inhibits the action of a cytokine believed to be the primary driver behind the condition.
- Effective treatment of atopic dermatitis can transform the lives of people with the condition who otherwise may suffer from an inability to sleep, social stigmatization, frequent extreme discomfort, and social isolation.
EBGLYSS is now approved for adults and children 12 years…
Read the full article here